High Recurrence Score Linked with Chemotherapy Success in Breast Cancer
The results of the TAILORx trial went against previous ideas that breast cancer patients with a high Oncotype score who needed chemotherapy and endocrine therapy wouldn ' t fare well.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news